DARPA Awards Inflammatix Up to $1.1M for Diagnostic to Predict Covid-19 Severity
Inflammatix, Burlingame, Calif, a pioneering molecular diagnostics company, announced that the...
Read MorePosted by Melanie Hamilton-Basich | Oct 8, 2020 | Covid 19, Immunoassay |
Inflammatix, Burlingame, Calif, a pioneering molecular diagnostics company, announced that the...
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Hematology & Serology |
DiaSorin is now able to offer a complete testing solution for Hepatitis A, Hepatitis B, and Hepatitis C in the United States.
Read MorePosted by Melanie Hamilton-Basich | Oct 2, 2020 | Covid 19 |
Japanese scientists have demonstrated a quick, effective mass testing approach using saliva samples to detect covid-19 in asymptomatic individuals.
Read MorePosted by Laurie Bonner | Oct 2, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The Access Interleukin-6 assay is designed to assist physicians in the identification of severe inflammatory response in covid-19 patients.
Read MorePosted by Laurie Bonner | Oct 1, 2020 | Emerging & Zoonotic Diseases |
This rapidly emerging bacterial infection needs new diagnostics.
Read More